tiprankstipranks
Trending News
More News >
Avisa Diagnostics (FOGCF)
OTHER OTC:FOGCF
US Market

Avisa Diagnostics (FOGCF) Financial Statements

Compare
14 Followers

Avisa Diagnostics Financial Overview

Avisa Diagnostics's market cap is currently $1.93M. The company's EPS TTM is $; its P/E ratio is ―; Avisa Diagnostics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 20Dec 19
Income Statement
Total Revenue$ 277.83K$ 858.36K
Gross Profit$ 129.28K$ -1.94M
Operating Income$ -900.65K$ -2.73M
EBITDA$ -678.64K$ -3.24M
Net Income$ -715.76K$ -4.13M
Balance Sheet
Cash & Short-Term Investments$ 110.00K$ 426.27K
Total Assets$ 122.16K$ 522.60K
Total Debt$ 153.44K$ 0.00
Net Debt$ 43.44K$ -426.27K
Total Liabilities$ 647.94K$ 355.61K
Stockholders' Equity$ -525.78K$ 166.99K
Cash Flow
Free Cash Flow$ -452.28K$ -1.37M
Operating Cash Flow$ -452.28K$ -1.35M
Investing Cash Flow$ 0.00$ -27.92K
Financing Cash Flow$ 144.34K$ 0.00
Currency in USD

Avisa Diagnostics Earnings and Revenue History

Avisa Diagnostics Debt to Assets

Avisa Diagnostics Cash Flow

Avisa Diagnostics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.